ArticleJournal of medicinal chemistry2017

Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.

Shanshan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.